Nichtentzündliche Muskelschmerzen

Abstract

Muscle pain as a common symptom in daily practice frequently occurs as a non-specific accompanying symptom in multiple internal and neurological diseases. Primarily inflammatory or autoimmune muscular diseases are causing muscle pain. However, a number of non-inflammatory causes of pain can also be considered for differential diagnosis. These are presented in this article. In principle, a distinction must be made between focal and diffuse muscle pain. As an invasive diagnostic procedure, a muscle biopsy should only be performed as the last step in the diagnostic alogorithm. If diffuse muscle pain is only associated with slight muscle weakness or is completely absent, there is usually a primary rheumatic cause. Statins (HMG-CoA reductase inhibitors) can lead to rhabdomyolysis, muscle fiber atrophy and muscle necrosis by damaging the muscle fiber membrane. Myotonias are autosomal dominant or autosomal recessive inherited disorders of muscle function. The genetic defect leads to pronounced muscle stiffness. The cause of metabolic myopathies can be disorders of the carbohydrate, fat or purine metabolism. Fibromyalgia syndrome (FMS) is a non-inflammatory disease and, according to the current knowledge, recognized as the result of an exposure to physical, biological and psychosocial factors (biopsychological disease model). To help diagnosing FMS, pain regions and core symptoms (fatigue, sleep disturbances) can be detected using questionnaires (Widespread Pain Index [WPI] and Symptom Severity Scale [SSS]).

Muskelschmerzen sind ein häufiges Symptom in der täglichen Praxis. Bei vielen internistischen und neurologischen Erkrankungen können sie als unspezifische Begleitsymptomatik auftreten. Primär muskuläre Erkrankungen als Ursache der Muskelschmerzen sind oft entzündlicher oder autoimmuner Genese. Differenzialdiagnostisch kommt jedoch auch eine Reihe nichtentzündlicher Schmerzursachen in Betracht. Diese werden im Folgenden vorgestellt.

Schlüsselwörter

Begleitsymptomatik - paroxysmale Schmerzen - Statine - Muskelbiopsie - Fibromyalgiesyndrom

Key words

accompanying symptoms - paroxysmal pain - statins - muscle biopsy - fibromyalgia syndrome

Publication History

Article published online:
02 July 2020

• Literatur

• 1 Mader FH, Weißgerber H. Allgemeinmedizin und Praxis: Anleitung in Diagnostik und Therapie. Springer; 2007. 6. Auflage.
• 2 Lindemuth R, Dillmann U, Topka H. et al S1-Leitlinie Crampi/Muskelkrampf. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 2017 Im Internet (Stand: 24.03.2020): www.dgn.org/leitlinien
• 3 Schneider-Gold C, Ellrichmann G, Lehmann-Horn F. et al S1-Leitlinie Myotone Dystrophien, nicht dystrophe Myotonien und periodische Paralysen. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 2017 Im Internet (Stand: 24.03.2020): www.dgn.org/leitlinien
• 4 Deschauer M, Müller-Reible C, Rösler K. et al S1-Leitlinie Diagnostik von Myopathien. AWMF-Registernummer: 030/115. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 2016 Im Internet (Stand 24.03.2020): www.dgn.org/leitlinien
• 5 Heuß D, Bayas A, Schmidt J. et al Diagnostik und Differenzialdiagnose bei Myalgien, S1-Leitlinie, AWMF-Registernummer: 030/051. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 2020 Im Internet (Stand 24.03.2020): www.dgn.org/leitlinien
• 6 Clarkson PM, Kearns AK, Rouzier P. et al. Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc 2006; 38: 623-627
• 7 Mastaglia FL, Garlepp MJ, Phillips BA. et al. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003; 27: 407-425
• 8 Filosto M, Tonin P, Vattemi G. et al. The role of muscle biopsy in investigating isolated muscle pain. Neurology 2007; 68: 181-186
• 9 Lochmüller H, Reimers CD, Fischer P. et al Exercise-induced myalgia in hypothyroidism. Clin Invest 1993; 71: 999-1001 . doi:10.1007/bf00180031
• 10 Sieb JP, Gillessen T. Iatrogenic and toxic myopathies. Muscle Nerve 2003; 27: 142-156
• 11 Gold R, Kress W, Meurers B. et al. Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis. Muscle Nerve 1992; 15: 214-218
• 12 El-Tawil S, Al Musa T, Valli H. et al. Quinine for muscle cramps. Cochrane Database Syst Rev 2015; 4: CD005044
• 13 Deutsche Schmerzgesellschaft. Definition, Pathophysiologie, Diagnostik und Therapie des Fibromyalgiesyndroms. 2017 Im Internet (Stand: 24.03.2020): http://www.awmf.org/leitlinien/detail/ll/145-004.html
• 14 Uceyler N, Zeller D, Kahn AK. et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013; 136: 1857-1867
• 15 Martinez-Lavin M. Fibromyalgia and small fiber neuropathy: the plot thickens!. Clin Rheumatol 2018; 37: 3167-3171
• 16 Uceyler N. Small fiber pathology--a culprit for many painful disorders?. Pain 2016; 157 (Suppl. 01) S60-S66
• 17 Wolfe F, Brahler E, Hinz A. et al. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) 2013; 65: 777-785
• 18 Hauser W, Brahler E, Wolfe F. et al. Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: surveys with patients of three different settings. J Psychosom Res 2014; 76: 307-311
• 19 Hauser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci 2018; 20: 53-62
• 20 Wolfe F, Clauw DJ, Fitzcharles MA. et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016; 46: 319-329
• 21 Glueck CJ, Lee K, Prince M. et al. Low serum vitamin D, statin associated muscle symptoms, vitamin D supplementation. Atherosclerosis 2017; 256: 125-127
• 22 Hsiao MY, Hung CY, Chang KV. et al. Is Serum Hypovitaminosis D Associated with Chronic Widespread Pain Including Fibromyalgia? A Meta-analysis of Observational Studies. Pain Physician 2015; 18: E877-E887
• 23 Macfarlane GJ, Kronisch C, Dean LE. et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017; 76: 318-328
• 24 Hauser W, Bock F, Engeser P. et al. Long-term opioid use in non-cancer pain. Dtsch Arztebl Int 2014; 111: 732-740